Cargando…
High‐dose‐rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report
High‐dose‐rate interstitial brachytherapy (HDR‐ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR‐ISBT.
Autores principales: | Takagawa, Yoshiaki, Murakami, Naoya, Suzuki, Shigenobu, Matsumoto, Fumihiko, Yoshimoto, Seiichi, Itami, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787852/ https://www.ncbi.nlm.nih.gov/pubmed/31624595 http://dx.doi.org/10.1002/ccr3.2360 |
Ejemplares similares
-
Radiotherapy for localized sebaceous carcinoma of the eyelid: a retrospective analysis of 83 patients
por: Takagawa, Yoshiaki, et al.
Publicado: (2019) -
High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report
por: Takagawa, Yoshiaki, et al.
Publicado: (2022) -
Image-guided interstitial brachytherapy boost for nasopharyngeal carcinoma: technical aspects
por: Murakami, Naoya, et al.
Publicado: (2020) -
SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer
por: Takagawa, Yoshiaki, et al.
Publicado: (2022) -
Technical report: a high-dose-rate interstitial brachytherapy boost for residual sinonasal undifferentiated carcinoma
por: Miyata, Yusaku, et al.
Publicado: (2022)